Human liver and kidney cells convert 6 to 10 percent of added thyroxine to triiodothyronine in vitro at 37 degrees C. This extent of conversion is ten times greater than that in control studies with killed cells. Conversion is evident within 10 minutes and appears to be maximal within 1 hour. Greater net triiodothyronine formation results if greater amounts of exogenous thyroxine are added to the system, with no plateau evident even at very high thyroxine concentrations. The addition of high concentrations of nonradioactive triiodothyronine resulted in no evident inhibition of the conversion.
SUMMARY
The integrity of pituitary—adrenal function and growth hormone production was determined in 15 patients before and after treatment with diazepam (30 mg daily). There was no evidence of impairment; nor was the urinary excretion of catecholamines significantly altered. The reproducibility of the plasma corticosteroid response to insulin-induced hypoglycaemia was separately assessed and both the degree of fall in blood sugar and the rise in plasma corticosteroid level were found to be similar.
Summary
The pituitary‐adrenal response to stress and the production of growth hormone were studied in a group of schizophrenic patients before and after treatment with chlorpromazine in a dose of 300 mg daily for 1 week. Although there was a tendency for the growth hormone levels to be lower after treatment, the mean figures showed no significant differences. The mean plasma corticosteroid response to the stress of hypoglycaemia was only of significant difference at 120 min. Individual cases showed considerable, apparently random, variation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.